AudioSense Hearing, Balance & Concussion Celebrates Move to a New Exciting Location and Expanding Team
January 21, 2022 09:00 ET
|
AudioSense Hearing, Balance & Concussion
Toronto, Jan. 21, 2022 (GLOBE NEWSWIRE) -- An estimated 1.5 billion people across the globe experience some level of difficulty with their hearing, today. Hearing loss is an invisible disability,...
gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
January 12, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that its gammaCore™ nVNS device has received...
electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store
January 11, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce shop for patients...
electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine
January 10, 2022 16:01 ET
|
electroCore, Inc.
ROCKAWAY, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper,...
electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Jan. 04, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will...
electroCore, Inc. Provides Update on Global Distribution Partners
December 16, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into agreements...
electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom
December 15, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 15, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce...
Highmark Interactive Inc. expands footprint in Canadian Post Secondary Schools sports programs - adds University of Ottawa, Northern Alberta Institute of Technology (NAIT) and renews Okanagan Hockey Group
December 14, 2021 09:20 ET
|
Highmark Interactive
TORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Highmark Interactive (TSXV: HMRK) (“Highmark”), global leaders in mental and brain health digital technologies, today welcomes the addition of the Ottawa...
electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
December 14, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today provided an update on the ongoing...
electroCore Announces New Patent for Stroke and TIA Treatment
December 13, 2021 08:55 ET
|
electroCore, Inc.
ROCKAWAY, NJ, Dec. 13, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent...